GSTM1 and sickle cell disease: Prolongation of PT and increase in INR have been shown in patients with sickle cell disease, the increase being proportional to the severity of anaemia,26 and in a study of patients with haematological malignancies who were treated with chemotherapy,27 suggesting a delay in the initiation of the coagulation cascade in people with low Hb.